These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 19175554
1. Human platelet antigen typing of neonatal alloimmune thrombocytopenia patients using whole genome amplified DNA and a 5'-nuclease assay. Lemnrau AG, Cardoso S, Creary LE, Brown C, Miretti M, Girdlestone J, Navarrete CV. Transfusion; 2009 May; 49(5):953-8. PubMed ID: 19175554 [Abstract] [Full Text] [Related]
2. Determination of human platelet antigen typing by molecular methods: Importance in diagnosis and early treatment of neonatal alloimmune thrombocytopenia. Arinsburg SA, Shaz BH, Westhoff C, Cushing MM. Am J Hematol; 2012 May; 87(5):525-8. PubMed ID: 22345051 [Abstract] [Full Text] [Related]
3. High-throughput genotyping of human platelet antigens using the 5'-nuclease assay and minor groove binder probe technology. Higgins M, Hughes A, Buzzacott N, Lown J. Vox Sang; 2004 Aug; 87(2):114-7. PubMed ID: 15355503 [Abstract] [Full Text] [Related]
4. Genotyping for human platelet alloantigen polymorphisms: applications in the diagnosis of alloimmune platelet disorders. Curtis BR. Semin Thromb Hemost; 2008 Sep; 34(6):539-48. PubMed ID: 19085653 [Abstract] [Full Text] [Related]
5. Real-time PCR genotyping of human platelet alloantigens HPA-1, HPA-2, HPA-3 and HPA-5 is superior to the standard PCR-SSP method. Ficko T, Galvani V, Rupreht R, Dovc T, Rozman P. Transfus Med; 2004 Dec; 14(6):425-32. PubMed ID: 15569237 [Abstract] [Full Text] [Related]
6. Use of a rapid method for genotyping human platelet antigen systems in neonatal alloimmune thrombocytopenia. Porretti L, Lazzaroni S, Rebulla P, Poli F, Scalamogna M, Sirchia G. Haematologica; 1997 Dec; 82(5):600-1. PubMed ID: 9407731 [Abstract] [Full Text] [Related]
7. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for genotyping of human platelet-specific antigens. Garritsen HS, Fan AX, Bosse N, Hannig H, Kelsch R, Kroll H, Holzgreve W, Zhong XY. Transfusion; 2009 Feb; 49(2):252-8. PubMed ID: 18980617 [Abstract] [Full Text] [Related]
8. Molecular typing of HLA genes using whole genome amplified DNA. Creary LE, Girdlestone J, Zamora J, Brown J, Navarrete CV. Transfusion; 2009 Jan; 49(1):57-63. PubMed ID: 18954395 [Abstract] [Full Text] [Related]
9. Mass-scale high-throughput multiplex polymerase chain reaction for human platelet antigen single-nucleotide polymorphisms screening of apheresis platelet donors. Shehata N, Denomme GA, Hannach B, Banning N, Freedman J. Transfusion; 2011 Sep; 51(9):2028-33. PubMed ID: 21392014 [Abstract] [Full Text] [Related]
10. Alloantibodies against low-frequency human platelet antigens do not account for a significant proportion of cases of fetomaternal alloimmune thrombocytopenia: evidence from 1054 cases. Ghevaert C, Rankin A, Huiskes E, Porcelijn L, Javela K, Kekomaki R, Bakchoul T, Santoso S, Nutland S, Smyth DJ, Smith GA, McBride S, Watkins NA, Ouwehand WH. Transfusion; 2009 Oct; 49(10):2084-9. PubMed ID: 19500319 [Abstract] [Full Text] [Related]
11. Multicolor real-time polymerase chain reaction genotyping of six human platelet antigens using displacing probes. Ruan L, Pei B, Li Q. Transfusion; 2007 Sep; 47(9):1637-42. PubMed ID: 17725728 [Abstract] [Full Text] [Related]
12. Fetal-neonatal alloimmune thrombocytopenia and unexpected Glanzmann thrombasthenia carrier: report of two cases. Jallu V, Bianchi F, Kaplan C. Transfusion; 2005 Apr; 45(4):550-3. PubMed ID: 15819676 [Abstract] [Full Text] [Related]
13. Immunization against a low-frequency human platelet alloantigen in fetal alloimmune thrombocytopenia is not a single event: characterization by the combined use of reference DNA and novel allele-specific cell lines expressing recombinant antigens. Kroll H, Yates J, Santoso S. Transfusion; 2005 Mar; 45(3):353-8. PubMed ID: 15752152 [Abstract] [Full Text] [Related]
14. Neonatal alloimmune thrombocytopenia due to HPA-9b incompatibility. Raj A, Kailasnath VP, Bertolone S, McFarland JG. Pediatr Blood Cancer; 2009 Sep; 53(3):459-61. PubMed ID: 19459189 [Abstract] [Full Text] [Related]
15. Heterogeneity of HPA-3 alloantibodies: consequences for the diagnosis of alloimmune thrombocytopenic syndromes. Socher I, Zwingel C, Santoso S, Kroll H. Transfusion; 2008 Mar; 48(3):463-72. PubMed ID: 18067506 [Abstract] [Full Text] [Related]
16. DNA quantification of whole genome amplified samples for genotyping on a multiplexed bead array platform. Hansen HM, Wiemels JL, Wrensch M, Wiencke JK. Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1686-90. PubMed ID: 17684147 [Abstract] [Full Text] [Related]
17. Single-nucleotide-polymorphism genotyping for whole-genome-amplified samples using automated fluorescence correlation spectroscopy. Bannai M, Higuchi K, Akesaka T, Furukawa M, Yamaoka M, Sato K, Tokunaga K. Anal Biochem; 2004 Apr 15; 327(2):215-21. PubMed ID: 15051538 [Abstract] [Full Text] [Related]
18. Relevance of the HPA-15 (Gov) polymorphism on CD109 in alloimmune thrombocytopenic syndromes. Ertel K, Al-Tawil M, Santoso S, Kroll H. Transfusion; 2005 Mar 15; 45(3):366-73. PubMed ID: 15752154 [Abstract] [Full Text] [Related]
19. Direct comparison between two quantitative assays in the measurement of maternal anti-HPA-1a antibody in neonatal alloimmune thrombocytopenia (NAIT). Bessos H, Killie MK, Matviyenko M, Husebekk A, Urbaniak SJ. Transfus Apher Sci; 2008 Dec 15; 39(3):221-7. PubMed ID: 18945639 [Abstract] [Full Text] [Related]
20. Comparison of two whole genome amplification methods for STR genotyping of LCN and degraded DNA samples. Ballantyne KN, van Oorschot RA, Mitchell RJ. Forensic Sci Int; 2007 Feb 14; 166(1):35-41. PubMed ID: 16687226 [Abstract] [Full Text] [Related] Page: [Next] [New Search]